Scarica l'app Stockscreener
26.78
1.33%
-0.36
Dopo l'orario di chiusura:
27.00
0.22
+0.82%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché PHG Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$27.14
Aprire:
$27.14
Volume 24 ore:
935.36K
Relative Volume:
1.00
Capitalizzazione di mercato:
$25.48B
Reddito:
$20.19B
Utile/perdita netta:
$1.03B
Rapporto P/E:
25.06
EPS:
1.0687
Flusso di cassa netto:
$966.68M
1 W Prestazione:
+2.02%
1M Prestazione:
-16.31%
6M Prestazione:
-0.15%
1 anno Prestazione:
+4.24%
Intervallo 1D:
$26.77
$27.19
Intervallo di 1 settimana:
$26.61
$27.66
Portata 52W:
$21.48
$33.44
Koninklijke Philips N V Adr Stock (PHG) Company Profile
Nome
Koninklijke Philips N V Adr
Settore
Industria
Telefono
-
Indirizzo
-
Compare PHG vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PHG
Koninklijke Philips N V Adr
|
26.78 | 25.48B | 20.19B | 1.03B | 966.68M | 1.0687 |
ABT
Abbott Laboratories
|
103.99 | 180.70B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.44 | 125.40B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.14 | 111.88B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.17 | 102.80B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
79.34 | 45.74B | 6.07B | 1.06B | 1.34B | 1.8063 |
Koninklijke Philips N V Adr Stock (PHG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-17 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2025-02-25 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
| 2025-02-20 | Aggiornamento | UBS | Neutral → Buy |
| 2024-10-29 | Aggiornamento | Jefferies | Underperform → Hold |
| 2024-05-13 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-05-07 | Aggiornamento | Exane BNP Paribas | Underperform → Neutral |
| 2024-04-30 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2024-04-30 | Aggiornamento | UBS | Sell → Neutral |
| 2024-02-07 | Downgrade | Exane BNP Paribas | Outperform → Underperform |
| 2023-07-12 | Iniziato | Goldman | Buy |
| 2023-01-17 | Downgrade | UBS | Neutral → Sell |
| 2022-10-18 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-10-14 | Downgrade | Deutsche Bank | Hold → Sell |
| 2022-09-12 | Aggiornamento | Societe Generale | Hold → Buy |
| 2022-09-06 | Aggiornamento | UBS | Sell → Neutral |
| 2022-07-25 | Downgrade | Societe Generale | Buy → Hold |
| 2022-06-16 | Downgrade | UBS | Neutral → Sell |
| 2022-01-20 | Downgrade | Jefferies | Buy → Hold |
| 2022-01-14 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2022-01-12 | Downgrade | Citigroup | Buy → Neutral |
| 2021-09-08 | Iniziato | Jefferies | Buy |
| 2021-07-08 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-06-21 | Downgrade | HSBC Securities | Buy → Hold |
| 2021-03-18 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-07-28 | Iniziato | Societe Generale | Buy |
| 2019-07-30 | Iniziato | Citigroup | Buy |
| 2018-02-12 | Aggiornamento | Berenberg | Hold → Buy |
| 2017-11-09 | Downgrade | JP Morgan | Overweight → Neutral |
| 2017-10-16 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| 2017-06-21 | Downgrade | Natixis Bleichroeder | Buy → Neutral |
| 2017-04-25 | Downgrade | Societe Generale | Buy → Hold |
| 2016-12-12 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2016-11-23 | Iniziato | Citigroup | Buy |
| 2016-05-11 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
| 2016-03-01 | Aggiornamento | HSBC Securities | Reduce → Hold |
| 2016-02-16 | Downgrade | Jefferies | Hold → Underperform |
| 2015-11-27 | Iniziato | ING Group | Hold |
| 2015-09-08 | Iniziato | Credit Suisse | Outperform |
| 2015-08-27 | Aggiornamento | Nomura | Neutral → Buy |
| 2015-07-28 | Aggiornamento | Societe Generale | Hold → Buy |
| 2011-01-25 | Downgrade | HSBC Securities | Overweight → Neutral |
| 2009-12-07 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2009-10-16 | Aggiornamento | HSBC Securities | Neutral → Overweight |
| 2009-05-08 | Downgrade | UBS | Buy → Neutral |
Mostra tutto
Koninklijke Philips N V Adr Borsa (PHG) Ultime notizie
FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair - Finviz
Philips launches IntraSight Plus to simplify coronary interventions and advance precision care - Finviz
Philips launches IntraSight Plus to simplify coronary interventions and advance precision care - GlobeNewswire Inc.
Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant - Finviz
Philips convenes the Annual General Meeting of Shareholders 2026 - Finviz
Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment - Finviz
Koninklijke Philips (ADR) Stock Gains Traction as Earnings Beat Expectations Amid Health Tech Recove - AD HOC NEWS
PHIA Stock Price and Chart — EURONEXT:PHIA - TradingView
Philips expands digital pathology portfolio with cloud-enabled Philips IntelliSite Pathology Solution on HealthSuite - Finviz
Philips connects patient monitoring and diagnostics to advance platform-based care intelligence at HIMSS26 - Finviz
Philips Sonicare unveils two new electric toothbrush ranges alongside refreshed brand direction - Finviz
Philips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high-demand imaging environments - Finviz
SHERPA research consortium initiates seven clinical studies to validate AI-based assistive technologies for minimally invasive brain and cancer treatments - Finviz
Owlet Stock Before Q4 Earnings: Buy Now or Wait for Results? - Finviz
Philips introduces InkSpace Imaging's Snuggle flexible pediatric MRI coil for its 3.0T MR systems, helping to enhance imaging precision, efficiency and comfort - Finviz
Philips (PHG) Soars to 52-Week High on Strong Earnings, Upbeat Outlook - Finviz
SEISMIC consortium secures EUR 23.5 million IHI grant to pioneer next-generation minimally invasive brain treatments - Finviz
Earnings call transcript: Philips Q4 2025 earnings beat EPS forecasts - Investing.com
Philips proposes to re-appoint CEO Roy Jakobs - Finviz
PreciseOnco research consortium awarded EUR 14.9 million IHI grant to drive breakthroughs in precision cancer treatment - Finviz
Philips named a Clarivate Top 100 Global Innovator for the 13th consecutive year - Finviz
18 of the Best Stocks and ETFs to Buy Based on 2026 Expert Forecasts - Morningstar
Sony Group Corp. ADR outperforms competitors despite losses on the day - MarketWatch
Price Over Earnings Overview: Koninklijke Philips - Sahm
Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI - Finviz
Philips Bets On AI To See Inside Arteries With SpectraWAVE Buy - Sahm
Philips CEO Warns About 2026 Growth Target, Stock Drops - Sahm
AI-Powered Remote Electrocardiogram (ECG) Monitoring Market Report 2025 - GlobeNewswire Inc.
Koninklijke Philips N.V. (PHG): A Bull Case Theory - Finviz
Philips expands commercial availability of world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy - Sahm
Philips unveils BlueSeal Horizon, industry's first helium-free 3.0T MRI platform - Finviz
Philips launches Verida, world's first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision - Finviz
Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision - Sahm
Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform - Sahm
Creative Planning Has $1.38 Million Stock Position in Koninklijke Philips N.V. $PHG - Defense World
Koninklijke Philips N V Adr Azioni (PHG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.81%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):